[1]
“Targeted Therapies and their Associated Molecular Alterations in the Treatment of Renal Cell Carcinoma”, LJMHR, vol. 25, no. 6, pp. 25–37, Jun. 2025, Accessed: Feb. 02, 2026. [Online]. Available: https://journalspress.uk/index.php/LJMHR/article/view/1364